Luxendo

About

Luxendo develops and manufactures proprietary light-sheet fluorescence microscopy instruments.

Heidelberg,Baden-Wurttemberg,Germany
11 - 50

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: €8M
Industries: Bioinformatics,Biotechnology,Manufacturing
Founded date: Jan 1, 2015
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: LUXENDO GmbH

Luxendo will manufacture and sell advanced Single Plane Illumination Microscopes (SPIM) originally developed at EMBL by Lars Hufnagel and his team. SPIM is a rapidly emerging technology that combines optical sectioning with multiple-view imaging to observe tissues and living organisms with impressive resolution. Unlike the conventional techniques of widefield and confocal fluorescence microscopy, the light sheet technique illuminates on the region surrounding the focal plane of the detection objective in a twin objective configuration.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

2

€14M

Luxendo has raised a total of €14M in funding over 2 rounds. Their latest funding was raised on Jan 12, 2017 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jan 12, 2017	Series A	€8M	3	EMBL Ventures EMBLEM Technology Transfer LSP BioVentures	—	Detail
Oct 14, 2015	Series A	€6M	2	EMBL Ventures Life Sciences Partners	—	Detail